Covered recipient · General Payments record
MICHELLE JONES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$5,981.79
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,098.41 | 21 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $409.22 | 5 |
| Amgen Inc. | $360.80 | 3 |
| Gilead Sciences, Inc. | $247.11 | 2 |
| Kyowa Kirin, Inc. | $154.43 | 2 |
| Teva Pharmaceuticals USA, Inc. | $135.19 | 1 |
| ITI, Inc. | $125.33 | 1 |
| Axsome Therapeutics, Inc. | $124.65 | 1 |
| Novo Nordisk AS | $120.90 | 1 |
| Alexion Pharmaceuticals, Inc. | $118.63 | 1 |
| Otsuka America Pharmaceutical, Inc. | $117.67 | 1 |
| COLOPLAST CORP | $83.55 | 1 |
| Neurelis, Inc. | $79.94 | 1 |
| Lilly USA, LLC | $20.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.99 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107422098 | CMS |
| ABBVIE INC. | $22.43 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107422100 | CMS |
| ABBVIE INC. | $22.00 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107422102 | CMS |
| ABBVIE INC. | $114.80 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107422104 | CMS |
| ABBVIE INC. | $125.00 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107422106 | CMS |
| Alexion Pharmaceuticals, Inc. | $118.63 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093957532 | CMS |
| Amgen Inc. | $122.55 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117290099 | CMS |
| Amgen Inc. | $147.21 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117290101 | CMS |
| Amgen Inc. | $91.04 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117290097 | CMS |
| Axsome Therapeutics, Inc. | $124.65 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148394363 | CMS |
| COLOPLAST CORP | $83.55 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117432129 | CMS |
| Gilead Sciences, Inc. | $130.63 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133687449 | CMS |
| Gilead Sciences, Inc. | $116.48 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133687451 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125.33 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143519427 | CMS |
| Kyowa Kirin, Inc. | $63.39 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127054019 | CMS |
| Kyowa Kirin, Inc. | $91.04 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127054017 | CMS |
| Lilly USA, LLC | $20.99 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135834452 | CMS |
| Neurelis, Inc. | $79.94 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665705 | CMS |
| Novo Nordisk Inc | $120.90 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100585966 | CMS |
| Otsuka America Pharmaceutical, Inc. | $117.67 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119106802 | CMS |
| Teva Pharmaceuticals USA, Inc. | $135.19 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151570657 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.